Hummingbird Bioscience

Hummingbird Bioscience is a Singapore-based precision biotherapeutics company that has made strategic direct investments in U.S. early-stage life sciences companies. It is most relevant for biotechnology, pharmaceuticals and oncology founders developing antibody-based therapeutics, ADCs, cancer or autoimmune-disease programs and seeking sector-aligned capital rather than a conventional venture fund.